A study on the efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infections.

Trial Profile

A study on the efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infections.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Oct 2015

At a glance

  • Drugs Peramivir (Primary)
  • Indications Influenza A virus infections; Influenza B virus infections; Influenza virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Feb 2012 Status changed from not stated to recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 11 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top